ADRX
ADARx Pharmaceuticals, Inc.
14.00$
-1.4%
vs. previous close
Closing price · As of: Nov 16, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | 150,694.2% | -1,059.8% | -3,644.9% | |
| – | 301.0% | 33.6% | 98.5% | |
| – | 551.0% | 39.1% | 201.9% | |
| – | 158,910.1% | -63.5% | -481.8% | |
| – | 476.9% | 3.6% | 49.2% | |
| – | 39.9% | 0.1% | 0.8% | |
| – | 24,221.2% | -124.3% | -720.4% | |
| – | 150,217.3% | -1,063.4% | -3,694.1% |
Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.